SYRS

Syros Pharmaceuticals, Inc. Common Stock
SYRS

Overview Fund Activity
Delisted

SYRS was delisted on the 19th of March, 2025.

Back to rankings

35 hedge funds and large institutions have $176M invested in Syros Pharmaceuticals, Inc. Common Stock in 2016 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
35
Holders Change
+23
Holders Change %
+191.67%
% of All Funds
0.94%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
24
Increased
4
Reduced
4
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$48.6M
2
JPMorgan Chase & Co
2
JPMorgan Chase & Co
New York
$1.89M
3
BFA
3
BlackRock Fund Advisors
California
$1.73M
4
EC
4
EcoR1 Capital
California
$882K
5
AIC
5
AWM Investment Company
New York
$660K

Top Sellers

1
AC
1
Aisling Capital
New York
$7.05M
2
DM
2
Deerfield Management
New York
$25.1M
3
FCMI
3
Foresite Capital Management III
California
$832K
4
RG
4
Redmile Group
California
$11.7M
Name Holding Trade Value Shares
Change 		Shares
Change %
BIT
26
BlackRock Institutional Trust
California
$90K +$90K +646 New
TA
27
Teachers Advisors
New York
$68K +$68K +493 New
BIM
28
BlackRock Investment Management
Delaware
$34K +$34K +244 New
TRCT
29
Tower Research Capital (TRC)
New York
$21K +$21K +154 New
SO
30
STRS Ohio
Ohio
$20K +$20K +150 New
Barclays
31
Barclays
United Kingdom
$5K +$5K +37 New
Citigroup
32
Citigroup
New York
$5K +$5K +38 New
BNP Paribas Financial Markets
33
BNP Paribas Financial Markets
France
$2.3K +$2.3K +17 New
Creative Planning
34
Creative Planning
Kansas
$2K +$2K +18 New
Royal Bank of Canada
35
Royal Bank of Canada
Ontario, Canada
$1K +$1K +10 New
1
2